Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 2
2006 2
2009 1
2010 1
2011 1
2012 1
2013 2
2014 2
2015 1
2016 3
2017 3
2019 2
2020 4
2021 3
2022 4
2023 8
2024 11
2025 7
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean herguera juan (4 results)?
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.
Costa LJ, Bahlis NJ, Perrot A, Nooka AK, Lu J, Pawlyn C, Mina R, Caeiro G, Kentos A, Hungria V, Reece D, Niu T, Mylin AK, Hansen CT, Teipel R, Besemer B, Dimopoulos MA, Zamagni E, Yoshihara S, Kim K, Min CK, Geerts P, Van Leeuwen-Segarceanu E, Tyczynska A, Reguera JL, Johansson M, Hansson M, Turgut M, Grey M, Sidana S, Rodriguez-Otero P, Martinez-Lopez J, Hashmi H, Carson R, Kobos R, Sun W, Lantz K, Seifert A, Briseno-Toomey D, O'Rourke L, Rubin M, Vieyra D, Kang L, Mateos MV; MajesTEC-3 Trial Investigators. Costa LJ, et al. Among authors: reguera jl. N Engl J Med. 2026 Feb 19;394(8):739-752. doi: 10.1056/NEJMoa2514663. Epub 2025 Dec 9. N Engl J Med. 2026. PMID: 41363801 Free PMC article. Clinical Trial.
Alphavirus nsP3 organizes into tubular scaffolds essential for infection and the cytoplasmic granule architecture.
Kril V, Hons M, Amadori C, Zimberger C, Couture L, Bouery Y, Burlaud-Gaillard J, Karpov A, Ptchelkine D, Thienel AL, Kümmerer BM, Desfosses A, Jones R, Roingeard P, Meertens L, Amara A, Reguera J. Kril V, et al. Among authors: reguera j. Nat Commun. 2024 Sep 16;15(1):8106. doi: 10.1038/s41467-024-51952-z. Nat Commun. 2024. PMID: 39285216 Free PMC article.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Oliver-Caldés A, González-Calle V, Cabañas V, Español-Rego M, Rodríguez-Otero P, Reguera JL, López-Corral L, Martin-Antonio B, Zabaleta A, Inogés S, Varea S, Rosiñol L, López-Díaz de Cerio A, Tovar N, Jiménez R, López-Parra M, Rodríguez-Lobato LG, Sánchez-Salinas A, Olesti E, Calvo-Orteu M, Delgado J, Pérez-Simón JA, Paiva B, Prósper F, Sáez-Peñataro J, Juan M, Moraleda JM, Mateos MV, Pascal M, Urbano-Ispizua A, Fernández de Larrea C. Oliver-Caldés A, et al. Among authors: reguera jl. Lancet Oncol. 2023 Aug;24(8):913-924. doi: 10.1016/S1470-2045(23)00222-X. Epub 2023 Jul 3. Lancet Oncol. 2023. PMID: 37414060 Free article.
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Iacoboni G, Iraola-Truchuelo J, O'Reilly M, Navarro V, Menne T, Kwon M, Martín-López AÁ, Chaganti S, Delgado J, Roddie C, Pérez A, Norman J, Guerreiro M, Gibb A, Caballero AC, Besley C, Martínez-Cibrián N, Mussetti A, Sanderson R, Luzardo H, Iyengar S, Sánchez JM, Jones C, Sancho JM, Barba P, Latif AL, López-Corral L, Hernani R, Reguera JL, Sureda A, Garcia-Sancho AM, Bastos M, Abrisqueta P, Kuhnl A. Iacoboni G, et al. Among authors: reguera jl. Hemasphere. 2024 May 21;8(5):e62. doi: 10.1002/hem3.62. eCollection 2024 May. Hemasphere. 2024. PMID: 38774657 Free PMC article.
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy.
Torrent A, Morgades M, Iacoboni G, Reguera JL, Kwon M, López Corral L, Hernani R, Ortiz-Maldonado V, Sanz J, Caballero Gonzalez AC, Guerra L, Sánchez Pina JM, Mussetti A, Garcia-Sancho AM, Bastos-Oreiro M, Delgado J, Carpio C, Sancho JM, Pérez-Martinez A, Barba P. Torrent A, et al. Among authors: reguera jl. Bone Marrow Transplant. 2025 Dec;60(12):1675-1678. doi: 10.1038/s41409-025-02722-y. Epub 2025 Sep 30. Bone Marrow Transplant. 2025. PMID: 41028300 No abstract available.
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.
Iacoboni G, Navarro V, Sesques P, Rejeski K, Bastos-Oreiro M, Serpenti F, Martin Lopez AA, Iraola-Truchuelo J, Delgado J, Perez A, Guerreiro M, Caballero AC, Martinez-Cibrian N, Luzardo Henriquez H, Sanchez Pina JM, Sancho JM, Ghesquieres H, Mussetti A, Lopez Corral L, Hernani R, Reguera JL, Sureda A, Bosch F, Martin Garcia-Sancho A, Kwon M, Subklewe M, Kuhnl A, Bachy E, Barba P, Villacampa G, Abrisqueta P. Iacoboni G, et al. Among authors: reguera jl. J Hematol Oncol. 2024 Oct 29;17(1):102. doi: 10.1186/s13045-024-01608-8. J Hematol Oncol. 2024. PMID: 39468591 Free PMC article.
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.
Jordana-Urriza L, Serrano G, Camara-Peña S, Calleja-Cervantes ME, San Martin-Uriz P, Zabaleta A, Oliver-Caldes A, Español-Rego M, Alignani D, Lozano T, Rodriguez-Diaz S, Iglesias E, Cabañas V, Reguera JL, Gonzalez-Calle V, Mateos MV, Sanchez-Guijo F, Paiva B, Lasarte JJ, Inoges S, Lopez-Diaz de Cerio A, Gonzalez-Navarro A, Juan M, Fernandez de Larrea C, Tamariz E, Alfonso-Pierola A, Rodriguez-Otero P, San-Miguel JF, Hernaez M, Rodriguez-Madoz JR, Prosper F. Jordana-Urriza L, et al. Among authors: reguera jl. Blood Neoplasia. 2026 Feb 5;3(2):100203. doi: 10.1016/j.bneo.2026.100203. eCollection 2026 May. Blood Neoplasia. 2026. PMID: 42027747 Free PMC article.
Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h.
Munárriz D, Rodríguez-Lobato LG, López-Corral L, Arnaldos-Pérez C, Cabañas V, López-Muñoz N, Oliver-Caldés A, Ponce JC, Reguera JL, Martín AÁ, Martínez-Cibrián N, Tovar N, Delgado J, Guillen E, Varea S, Rodríguez-Otero P, Urbano-Ispizua Á, Moraleda JM, Martínez-López J, Mateos MV, De la Calle VG, González-Navarro EA, Fernández de Larrea C. Munárriz D, et al. Among authors: reguera jl. Front Immunol. 2025 Oct 16;16:1654096. doi: 10.3389/fimmu.2025.1654096. eCollection 2025. Front Immunol. 2025. PMID: 41181103 Free PMC article.
61 results